A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface JOURNAL OF NEURO-OPHTHALMOLOGY Ugradar, S., Kossler, A. L., Douglas, R., Cockerham, K. 2022; 42 (1): 26-34

View details for DOI 10.1097/WNO.0000000000001515

View details for Web of Science ID 000760427000009